Have a personal or library account? Click to login
Thermal evaluation of TECAR used in the treatment of active myofascial trigger point Cover

Thermal evaluation of TECAR used in the treatment of active myofascial trigger point

Open Access
|Aug 2025

Abstract

Introduction

This study aimed to evaluate the efficacy of TECAR therapy in treating MTrP using thermographic imaging as a diagnostic tool.

Material and methods

The study was conducted on a group of 13 volunteers aged 25 to 45 years (mean age 34.3 ± 6.4 years) who were diagnosed with active MTrP in the UT muscle. Thermography measured skin temperature changes in the treated areas before and after TECAR therapy.

Results

The study revealed a correlation between changes in skin temperature and clinical pain indicators, as measured by the NRS and PPT. Initial results showed no significant correlations between temperature parameters and pain scales. However, after seven days of TECAR therapy, a strong, positive correlation was observed between temperature and NRS scores (p = 0.004, r = 0.8), suggesting that TECAR therapy affects temperature in the MTrP area, resulting in a pain decrease.

Conclusions

The results obtained over 30 days of therapy showed variability in thermal response, indicating the need for further research to fully understand the mechanisms of action of TECAR therapy in the treatment of MTrP. Nevertheless, the observed strong correlation after seven days of therapy suggests promising possibilities for using thermography to monitor treatment effects.

DOI: https://doi.org/10.2478/pjmpe-2025-0027 | Journal eISSN: 1898-0309 | Journal ISSN: 1425-4689
Language: English
Page range: 239 - 245
Submitted on: Mar 24, 2025
|
Accepted on: Jul 24, 2025
|
Published on: Aug 28, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Tomasz Piętka, Klaudia Duch, Karolina Sieroń, Agnieszka Kiełboń, Teresa Kasprzyk-Kucewicz, published by Polish Society of Medical Physics
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.